These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4401505)

  • 1. On the effect of pharmaceutical formulation on thioridazine absorption.
    Hirst CA; Kaye RC
    J Pharm Pharmacol; 1971 Dec; 23():246S-247S. PubMed ID: 4401505
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Serum-thioridazine levels after different dosage forms.
    Viukari NM; Salmimies P
    Lancet; 1973 Dec; 2(7840):1271. PubMed ID: 4128602
    [No Abstract]   [Full Text] [Related]  

  • 3. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
    Corrigan OI; Timoney RF
    Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: The comparison of the bioavailabilities of commercial nitrofurantoin tablets.
    McGilveray IJ; Mattok GL; Hossie RD
    Rev Can Biol; 1973; 32():Suppl:99-106. PubMed ID: 4777608
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenolic metabolites of thioridazine in man.
    Papadopoulos AS; Crammer JL; Cowan DA
    Xenobiotica; 1985 Apr; 15(4):309-16. PubMed ID: 4024665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of thioridazine bioequivalence.
    Barone JA; Colaizzi JL
    Drug Intell Clin Pharm; 1985 Nov; 19(11):847-58. PubMed ID: 3905323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Penicillins: use of an animal model to predict bioavailability.
    Poole JW
    Rev Can Biol; 1973; 32():Suppl:43-51. PubMed ID: 4204778
    [No Abstract]   [Full Text] [Related]  

  • 8. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
    Vogelpoel H; Welink J; Amidon GL; Junginger HE; Midha KK; Möller H; Olling M; Shah VP; Barends DM
    J Pharm Sci; 2004 Aug; 93(8):1945-56. PubMed ID: 15236445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioavailability of different brands of phenoxymethylpenicillin (author's transl)].
    Simon C; Malerczyk V; Grothkopp J
    Med Klin; 1975 Oct; 70(41):1637-40. PubMed ID: 810652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of drug absorption and of drug solution.
    Jollow DJ; Brodie BB
    Pharmacology; 1972; 8(1):21-32. PubMed ID: 4644653
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood levels of thioridazine and some of its metabolites in psychiatric patients. A preliminary report.
    Buyze G; Egberts PF; Muusze RG; Poslavsky A
    Psychiatr Neurol Neurochir; 1973; 76(3):229-39. PubMed ID: 4725794
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug bioavailability studies.
    Wagner JG
    Hosp Pract; 1977 Jan; 12(1):119-27. PubMed ID: 838484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
    Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
    Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioridazine plasma levels and clinical response.
    Gottschalk LA; Biener R; Noble EP; Birch H; Wilbert DE; Heiser JF
    Compr Psychiatry; 1975; 16(4):323-37. PubMed ID: 1098848
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect and plasma level of thioridazine.
    de Jonghe FE; van der Helm HJ; Schalken HF; Thiel JH
    Acta Psychiatr Scand; 1973; 49(5):535-45. PubMed ID: 4586599
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Mechanisms of drug absorption and of drug solution.
    Jollow DJ
    Rev Can Biol; 1973; 32():Suppl:7-19. PubMed ID: 4777606
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERUM CONCENTRATIONS OF THIORIDAZINE AFTER DIFFERENT ORAL MEDICATION FORMS.
    MELLINGER TJ
    Am J Psychiatry; 1965 May; 121():1119-22. PubMed ID: 14288952
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum concentration and elimination from serum of thioridazine in psychiatric patients.
    Axelsson R; Mårtensson E
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):242-65. PubMed ID: 813963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.